1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Bend Bioscience Acquires Societal CDMO

M&A Deal Summary

Bend Bioscience Acquires Societal CDMO

On April 8, 2024, Bend Bioscience acquired life science company Societal CDMO for 130M USD

Acquisition Highlights
  • This is Bend Bioscience’s 1st transaction in the Life Science sector.
  • This is Bend Bioscience’s largest (disclosed) transaction.
  • This is Bend Bioscience’s 1st transaction in the United States.
  • This is Bend Bioscience’s 1st transaction in Georgia.

M&A Deal Summary
Date 2024-04-08
Target Societal CDMO
Sector Life Science
Buyer(s) Bend Bioscience
Deal Type Add-on Acquisition
Deal Value 130M USD
Advisor(s) Raymond James - Investment Banking (Financial)
Goodwin Procter (Legal)

Target

Societal CDMO

Gainesville, Georgia, United States
Societal CDMO is a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products. Societal CDMO was formed in 2007 and is based in Gainesville, Georgia.

Search 215,074 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Bend Bioscience

Clearwater, Florida, United States
Category Company
Founded 2006
Sector Life Science
DESCRIPTION

Bend Bioscience is a provider of clinical and commercial CDMO services to a wide range of small to mid-sized pharmaceutical and biotech clients. Bend Bioscience was founded in 2006 and is based in Clearwater, Florida.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Georgia M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2024 M&A 1 of 1
Size (of disclosed) 1 of 1
Mergr

Solution for

Product

Company

Legal